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ime&mal views 
ribution of polon 
D&utaminc stress echocardiography has become an accepted 
technique for assessment of patients with coronary artery 
disease because of its ability to detect coronary lesions (l-6). 
and also because it may provide prognostic information in 
patients undergoing noncardiac surgery (7,g) and i  those with 
stable forms of ischemic heart disease (9). More recently, low 
dose dobutamine echocardiography , ..s been proposed to 
identity dyssynergic but viable myocardium after a recent 
myocardial infarction (“stunned” myocardium) (10-12) and in 
chronic left ventricular dysfunction (“hibernating” myocar- 
dium) (13,14). 
Despite these beneficial attributes of dobutamine stress 
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diagnostic accuracy of the test. 
~~~~1~~5~. Transe 
rapby is 51 safe, teas 
comua~ artery disease. 
echocardiography, the technique is limited in that uhrasound 
imaging of the heart with the conventional transthoracic 
approach is poor in some patients. Furthermore, even in 
patients in whom subjective assessment of regional wall motion 
is feasible, reliable measurements of myocardial thickening 
may not be derived because of poor endocardidl visualization,. 
This drawback becomes more important when most needed, as 
in patients with left ventricular dysfunction i  whom accurate 
measurements of wall thickening may be critical to determine 
the presence of viable myocardium. 
Transesophageal chocardiography as been used for many 
years as an alternative to the conventional transthnracic exam- 
iMion because of its ability to provide high quality images in 
virtually every patient (lS,i6). Recently, transesophageal cho- 
cardiography has been combined with stress induced by atrial 
pacing (17-20) or by dipyridamole (21) in patients with 
coronary artery disease; however, its use with dobutamine 
stress has nlot been reported to date. The purpose of the 
present study, therefore, was to determine the safety, feasibility 
and diagnostic accuracy of multiplane transesophageal dobut- 
0735 1097/94/$7.00 
amine stress edloca 1y for the assessment of ischemjc 
d group of patients un 
evahatisn of known or 
induded in the present 
COlWliWy XEW)J W one of :¶s major bran&es. Left main9 
coron9uy artery disease wi9s considered prcscnt W~ICII this 
artery had >JO% huuen stenosis. No patient had a myozardial 
infarctio99 it9 tbe 3 months before the study. 
evidence of cardio~~yopatby, congenital or valv 
ease, recent m}~ocardia~ infarction, unstable angina or uncon- 
troilfld systemic hypertension were exccluded frou~ the st99dy. 
All patients had sinus rhythm. A99tiangi99al medications were 
withdrawn 248 In before the performance of the stress echo- 
cardiograa9. Twenty-three study patients had bad a previo99s 
myocardial infarction. Twenty patients had undergone previ- 
ous rc,,~rcularizntion (coronary artery bypass urgery in 14 
patients and angioplasty in6); in these patients, the status of 
the coronary tree at the time of the 9nost recent cardiac 
catheterization (performed after revascularizarion in ait pa- 
tients) was Lse9. when ctassifyi99g patients according to the 
presence of one-, two- or three-vessel disease. 
The study was approved by the National Heart, Lung, and 
Blood Institute fnvestigational Review Board and each patient 
Before the transesophageal study, each 
patient underwent a conventional transthoracic echocardio- 
graphic examination performed by an experienced sonogra- 
pher utilizing a Hewlett-Packard (Sonos 10’30 or Sonos 1500) 
real time, phased array, 90” sector scanner with a 2SMHz 
transducer, Two-dimensional images were obtained in severA 
cross-sectional planes by using standard transducer positio99s 
(22). Particular attention was paid to obtaining the best 
possible imaging of the different left ventricular segments in 
the parasternal long- and short-axis views and in the apical 
four- and two-chamber views in eact9 patient. Studies were 
recorded on videotape for subsequent review and analysis. 
Transthoracic echocardiograms were analyzed by a reviewer 
unaware of the results of transesophageal dobutamine stress 
echocardiography or coronary angiography. 
Exercise testing. Patients uadenvent a symptom-limited 
exercise test using either the stardard Bruce protocol (23) or 
the National Institutes of Health combined protocol (24). 
TwAve-lead electrocar iograms (ECGs) were obtained at rest, 
urmg exercise and at peak exercise. g%n the 
as replaced by lead CM,. The exercise was 
positive when planar 0, 
ion 21 mm at 0.08 s after ahe 
cardiograms were perform a 
e (42 patients) or orn~~~~a~e (34 pa- 
tients) ~-MHZ probe. ‘fn 75 of the ‘?6 study patients, transesoph- 
ageal dobutamine stress echocardiogralns and coronary an- 
giography were performed during the same week; the 
~~~~~~9~9~i~~ patier* underwent the ~buta9~iio~ stress test with99 
2 ~9~~)9~t~~s ~)~~~ ( i~~ c~~~~~~~~i~~~(~~. Coronary ~lflg~ogra~hy was 
performed before the transesophageal dobutamme stress 
cchocardiogram in 43 patients: this order was rcvcrsed in the 
OBhCr. 3.1. Nij ~Mliellt experienced a change in sy9nptons 
betwee the performance of the two studies. 
Tbe studies were performed wi the patient in the left 
lateral decubitus position. The oral 
with aeroso! benzocaine sprajr. in 
nnidazolam hydrochloride was administered before introduc- 
of the probe and during the study as needed (the total 
of midazokun used was 6 1- 2 mg). Par introduction of the 
e, patients were sedated to a point at which they were on 
e verge of falling asleep but still able to follow comnlands 
such as swallowing. This was usually accomplished with a dose 
of midazolam of 1.5 to 2.5 mg, depending on the patient’s age 
and weight. Duri99g the procedure, patients were maintained at
a level of sedation i which they could comfortably tolerate the 
study and refer to the development ofsynlptoms such as chest 
discomfort. This was achieved by additional I- or 2-mg doses of 
midalozam as needed. Heart rate and oxygen sat999 a ioar v ere 
continuously monitored uring the study. A IZlead ECG and 
9neasuren9ents GE systemic blood pressure were recorded at the 
end of each stage of the dobutamine protocol while the 
echocardiographic images were obtained. 
Dobutamine was infused at a starting rate of 2.5 pg/kg body 
weight per min. After 5 min, the dose was increased to 5 kg/kg 
per min. Subsequently, hedose was increased by 5-pg/kg per 
nun every 5 min to a maximum of 40 pg./kg per min. TWO- 
dimensional views were acquired uring the last 2 min of each 
stage, The stress test was terminated when the maximal dose of 
dobutam;ne WBS reaclred or when severe chest pain, a severe 
increase in systolic blood pressure (>250 mm Hg), clinically 
sig99ificant rrhythmias, extensive wall motion abnormalities or 
intolerance to the prche develope . A decrease ira blood 
pressure not accompanied by development of extensive wall 
motion nbnormalitics was not considered a criterion for ter- 
mination of the test (25,26). Sublingual nitroglycerin, n fedi- 
pine and intravenous propranolol were available. 
At baseline and at each stage of the dobutamine infusion, 
transgastric short-axis and transesophageal long-axis, four- and 
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Left anterior dwndinp) distribution 
Right coronary artery dislribution 
Left circumflex distribution 
two-chamber views were obtained in the following sequence. 
First, the transgastric short-axis view was obtained at both the 
papillary muscle and the mitral valve levels. Then the probe 
was pulled out to the esophagus, and the long-axis. four- 
chamber and two-chamber views were re~~~rde~~ ~rn~~~diat~ly 
after completion of die ima c ~~~q~~isiti~u, the dose of dobut- 
amine was incrcascd to the next level and the probe was g&y 
advanced again across the cardias and into tke stomach to start 
with the transgastric short-axis view during the next stage. The 
long-axis view was obtained by lateral flexion of the ~on~itudi- 
nal probe when the biplane probe was used (27) and by 
rotating the transducer 135” from the horizontal position when 
the omniptane probe was tised (28). 
Two-dimensional views were continuously recorded on 
videotape and digitized on-line by utilizing an Image VW 
system (Nova Micro.sonics). This system permits creation of a 
continuous loop of a single cardiac cycle by displaying still 
frames acquired at regular intervals in a continuous fashion. 
Twelve sequential fmmes of each two-dimensional view were 
captured at 33”ms intervals with an ECG-triggered mechanism 
at ba.seline and with each dose of dobutamine. 
In Iyssis. Transesophageal e~h~ardiog~~hi~ im- 
ages digitized on-line during thp: dobu~mine stress study were 
transferred to optical disks for permanent storage and review. 
Images were reviewed by two observers who bad no knowledge 
of the results of the coronary angiograms, exercise tests and 
ECGs during dobutamine infusion. The initial separate image 
analysis was then used to assess interobserver variability. In 
calies of disagreement, the studies were again reviewed and a 
consensus was reached between the two observers. At each 
Left anterior d~e~~~~~ircurn~e~ overlap 
Left anteriorltight coronary artew overlap 
LaR circumflsxkight coronary artery overlap 
stage of the dobutamine protocol, the left vtntricle w&s divided 
into 16 s~grn~uts according to the recommeil~tions of the 
American Society of ~~h~rdiog~~~by (29) (Fig. I ). ~~~~0~~~ 
myocardial contractile function was graded as nodular, hypoki- 
nesia. akinesia or dyskinesia in each myocardial segment; 
particular attention was paid to systolic wall thickening rather 
than to endocardial motion. 
A test result was considered negative when a graduai and 
consistent increase in systolic wall thickening with increasing 
doses of dobutamine was observed in each myocardial seg 
ment. A test result was considered positive when regional 
dyssynergy develorled (or worsened in segments with rest wall 
motion abnormalities) during dobutamine infusion in one or 
more m~~ardia~ segments compared with fiudiugs with the 
previous dobutamine dose. Evaluation of each myocardial 
segment was performed by using an integrated assessment 
from the different imaging planes available for analysis. Left 
ventricular segments were assigned to each major coro~dlry 
artery with the use of an ecbocardlographic model of distribu- 
tion of coronary perfusion similar to the one proposed by 
&gal et al. (30) (Fig. 1). In patients with regional wall motion 
abnormalities during baseline conditions, the development of 
regional dyssvnergy in a territory corresponding to a Merent 
coronapv artery was considered indicative of multivessel dis- 
ease. 
For cash patient, the number oi myocardial segments that 
cWId be properly assessed on both tb? franfhoracic and the 
bnseline transesophageal examination was determined. Imag- 
ing of a myocardial segment was considered to be suboptimal 
when the endocardial border c&d not be visualized through- 
out the cardiac cycle. 
L”itaUistieaB analysis. Sensitivity, specificity, predictive value 
and overall accuracy were calculated by using standard formu- 
las. Two means were compared with a paired or unpaired ! test. 
as apprqxiatr. Proportions cvcrc compared 1)~ the chi-square 
tc!it. bIti ikW prcscnted X IWaR VitlW _!I SD. A 12 V;lD\K < (I.WI 
was considered significant 
CWWIlaEy aU@gra@y. F~;‘cwrtWn $Mtie!ltS llild ~PiP~~Tl;li c’OI’- 
OOIiP!‘y ii@OgrikphiC BidillgS OF nonsiyhxnr coruilisry lesimik 
Sixty-tWU patients hid signilicant stenosis Of at Icast One ~1~i~jOl 
coronary artery. Of these, 25 patients (40%) had single-vessel 
disease, 20 (32%) had two-vessel disease and 17 (279;) had 
involvement of all three major coronary vessels. Of the 37 
patients with multivessel disease, 6 had >SO% stenosis of the 
left main stem. 
BaseDEnne ee~~~ea~~j~g~a~~~~~~ The number oi myocardial 
segments per patient in which visuaiizatiun of the endocardium 
was achieved throughout the cardiac cycle to allow for a 
distinct assessment of systolic thickening was 11.3 2 1.3 with 
transthoracic and 15.7 + 0.7 with transesophageal echocardi- 
ography (p < 0.0001). The numbcm of patients :;I whom <IO 
segments couid be thus visualized was IX (23G) with trans- 
?noracic and none (0%) with transesophageal echocardiogrn- 
phy (p < O.OOOl). The number of patients in whom at least 12 
ot‘ the 16 myocardial segments were imaged was 35 (46%) with 
aransthoracic and 7h (IOW) with transesophageal echocardi- 
ography (p +=c O.OOUl). At least I2 of the 1t1 segments were 
properly visualized in only 4 (29%) of the 14 patients with 
previous bypass surgery. 
Traasesophageall dobuaamnine stress echocar&ography. 
Dobutamine increased heart rate in a gradual and consistent 
fashion in every patient from 71 ? I4 beatslmin at baseline to 
a peak of 131 + 18 beats/min. In 28 patients, peak heart rate 
occurred at doses lower than the maximal dose of dobutamine 
achieved. The maximal dose of dobutamine used during the 
test was 27 + 13 pg/kg per min. 
The test was stopped because of completion of the protocol 
(achievement of the maximal dose of dobutamine) in 30 
patients, severe chest pain in 21, extensive wall motion abnor- 
malities in 17, severe systolic hyperteflsion (>250 mm Hg) in 3, 
nonsustained ventricular tachycardia in 1, significant (>4-mm) 
ST segment depression in 1 and mtolerance to the probe in 3. 
The test result was considered normal in 21 patients and 
abnormal in 55. Of the 21 patients with a normal dobutamine 
stress test response, 17 achieved 85% of the age-predicted 
Figaare 2. Incidence of new or worsening regional wall motion abnor- 
makics (positive study [hatched area]) during transesophageal dobut- 
amine stress echocardiography in 62 patients with angiographically 
documcntcd coronary artery disease (M) and 14 patients with normal 
coronary artcries (right). Solid area = negative study. 
maximal heart rate; of the remaikg 4 patients, the test was 
SloppcJ in 3 because of chest pain .rnd in 1 bct~+use of
inlolcriiuce to the prohu. 
NCW Or worsening regional Wi!ll nriblion ~bll~)~~~i~~~[~~~ dur- 
ing dobutaminc infusion developed in 55 of the 62 patients 
with coronary artery disease. None of the 14 patients with 
normal coronary arteries had positive dobutamine stress ecbo- 
cardiographic findings. Thus, the sensitivity of the test for 
detecrion of coronary artery disease was 89% and the specific- 
ity 100% (Fig. 2). The positive predictive value was 100% and 
the overall accuracy (number of tests with true positive plus 
true negative results divided by the total number of tests) was 
91’;;. 
Rcgionai wall motion abnormalities in the distribution of 
more than one major coronary aitery were seen in 3 of the 25 
patients with single-vessel coronary artcry discasc and in 30 of 
the 37 patients with multivessel disease (p < O.OOCll) (Fig. 3) 
Thus. among the patients with coronary artery disease, the 
sensitivity and specificity for diagnosis (A multivessel involve- 
ment were 81%’ and 88%, respectively (Fig. 4). Among the 62 
patients with coronary artety disease, there were no differences 
in the sensitivity with which transesophageal dohutamine stress 
echocardiography predicted disease of individual vessels, ac- 
cording to the distribution of new or worsening wall motion 
abnormalities (Table I). However. the speciiicity of the test 
was lower for the left anterior descending <oronary artery (6 
[27%] of 22 patients without stenosis of this vessel developed 
wall motion abnormalities in segments corresponding to its 
distribution) than for the other two major coronary vessels 
(Table 1). 
Safety and feasiroility of transesapbageal dobotamine stress 
echocardiography. The test was successfully completed in 73 
(96%) of the ‘?6 patients, with a total esophageal intujation 
time of 41 -+ 13 min. In ,hc remaining three patients, the test 
was discontinued because of intoierancc to the probe. Of thcsc 
three patients, two had developed wall motion abrlormalities 
before the test was stopped and therefore 1hc test wa:; consid- 
ered diagnostic; in the remaining patient, who had a normt!l 
corf.)nary augiogrdm, the probe had to be removed before the 
magma1 dose of dobutamine was reached anr’ without achieve- 
ment of 85% of the patient’s age-predicted maximal heart rate. 
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Figun 3. Scqucntial still-frame images ohlained from the four- 
chamber view in a 52-year old man with chest pain who undenvcnt 
transcsophagcal dobutamine stress echocardiography. The top panels 
include the images oh&cd in diustook (A) and at end-systoie (A’) 
during bclselinc r-onditions. The middle panels show the images in
diastoltl (W) and at en&systolc (B’) recorded during infusion f 5 @kg 
per min of dohutamine. Thebottom pan& show the images obtained 
in diasstole (C) and at end-systole (C’) during the maximid dose of 
dobutaminc infused in this patient (20 ~g&g per min). i\n increase in 
contractile force from baseline to S &kg per min of dobutamine is 
apparent in all myocardid regions. with reduction of left ventricular 
cavity at end-systole (A’ to B’i. in contrast to what is normally 
expected. a significant worseni?g in global left ventricular function 
develops at 20 @kg per min ot dobutaminc with significant hypoki- 
nesia ofthe basal segments and akin&a of the distal segments of both 
the intenrentricular septum and the lateral free wall (arrows). End- 
systolic diMion of the left ventricular cavity is readily apparent (C’). 
Subsequent coronary angiography demonstrated significant left main 
coronary artery stenosis. 
Thus, intolerance to the probe was the sole limiting factor in 
only i (1.3%) of the 76 study patients. 
No majct complications occurred in any of the 76 study 
patients. Minor complications developed in seven patients: 
nonsustained ventricular tachycardia in one, frequent prema- 
ture ventricular complexes in two, atria1 arrhythmias in two 
W%) 181%) 
Figure 4. Incidence of new or worsening wall motion a~morrna~~~~es in 
the distribution of more than one major ccronary vessel (hak.hed 
areas), according to a model of regional distribution of myocardial 
perfusion, in 29 p3ticnts with single-vcsse! (left) 0nd 34 gatierlts with 
multivessel (right) coronary artcry disease. 
;tnd hy~c)te~sio~ (>20 1~1~~~ g decrease in systolic blood 
pressure) intwo. In only one these seven patients (the one 
with nonsustained ventricular tachycardia) didthe test have to 
bc discontinued because of one of these c
patient bad left ventricular dysf~nctiol~ at re 
extensive wall motion ab~~~rrn~~iti~s dur ng 
sion. Thus, none of the side effects affected the diagnostic 
accuracy of the test. 
Dobutamine induced chest pain in 38 (50%) of the 76 study 
patients (31 with coronary artery disease and ‘1 with normid 
coronary arteries); however, sub~~~~g~~~~ ~~itr lyce~~m bad to be 
administered in ouly 2 of these patients. A~tl~o~gb nifedipine 
and intravenous propranolol were available for treatment of
hypertension r side rects, these drugs were not used in any 
patient. 
Exercise testing. Seventy-three (96%) of B 
patients (60 with coronary artery disease and 13 with normal 
coronary artcries) underwent a symptom-limited treadmill 
exercise t st utilizing either the standard Bruce protocol (27 
patients) or the National Institutes of Health combined pro- 
tocol (46 patients). The remaining three patients bad medical 
corlditions that precluded treadmill exercise (osteoarthritis n 
two and neuromuscular deficit in one), Heart rate increased 
from 79 z 13 to 136 2 22 beats/min. The test was stopped 
because of chest pain 26 patients, shortness of breath or 
fatigue in 43, significant ST segment depression i 1 and 
hypotension in 2. 
ST segment changes compatible with myocarrlia! khemia 
Table 1. Ability of Transesophageal Dobutamine Stress 
Echocardiography to Detect Stenoses of Individ;?: C-T=Y, 
Vessels in 62 Patients With Coronarv Arterv Disease 
Coronary Artery Sensitivity Specificity 
tcfl onkrior descending 83% 73% 
(33/40) ~lM22) 
Left circumflex Sic; 93% 
(27t33) (27129) 
Right 78% 
(31Mo) (Z, 
Numbers in parentheses indicate number of patients. 
OWdl 
Accuracy 
79% 
( 49/62) 
87% 
(54/62) 
80% 
(W62) 
alien& with coronary artery 
Gents without coronary artery 
exe&.e testing in the paGeHits 
was 55% with a spdkity of 
significant stenosis of the left anterior descending coronary 
artery. The other three patients had severe rest left ventricular 
dysfunction with a biphasic response to dohutamine (initial 
three-vessel disease in the two other patients. 
Of the 1,193 myocardial segmeuts analyzed in the 76 
patients, a concordant analysis of wall motion at rest between 
the two observers was made in 1,B21 regions (94%). Agree- 
ment between the two observers with regard to the response to 
dob~tamine was found in 1,085 myocardial segments (91%). 
Ninety-six (89%) of the 108 regions in which disagreement was 
found between the two observers howed rest wall motion 
abnorma~~t~es~ usually associated with severe global eft ven- 
tricular dysfunction. 
The results of the present study demonstrate hat trans- 
esophageal dobutamine stress echocardiography is a safe, 
feasible and accurate method for the assessment of patients 
with suspected or known coronary artery disease. Thus, our 
study of unsele. ted patients undergoing coronary angiography 
at our institution showed that the method had a high sensitivity 
(89%), specificity (108%) and overall accuracy (91%) for 
detection of coronary artery lesions. In addiLon, transesopha- 
geal dobutamine stress echocardiography proved to have a 
high sensitivity and specificity for identifying mu;tivessel dis- 
ease and for assessing myocardial ischemia in specific vascular 
territories. Thus, most of the patients with extensive coronary 
artery disease had wall motion abnormalities induced by 
dobutamine in the territory distribution of more than one 
major coronary artery. Conversely, most patients with single- 
wall motions abnor ahties limited to the 
distribution of only one major coronary vessel. 
when the response of tbe different ~yoc~rd~al seg 
wever, the specificity 
for detection of disease in the f - .~~if~ry of the left anterior 
descending coronary artery was somewhat lower than that 
observed in the distr~but~on of the other two major coronary 
vessels, and also l wer than that reported in previous studies of 
ress ecb~ca~diogra~liy (20,%1,24). 
es. The results Of our study are in general 
se of previous investigations utilizing stress 
The sensitivity of transesop 
amme stress echocardio~ra~by was si 
ems with coronary artery disease who under- 
c stress combined with tra~stl~~~acic echo ar- 
ination (l-6). However, the specificity was 
evions ~nvcst~gations using dobu 
ly (l-6), and in agreement w 
vious reports related to the 
t~a~seso~~agea~ echocardiography wi
stress, such as atrtal pacing (17-20) 
Finally, transesopbageal dobutamine stress echocardiography 
bad a significantly g ier sensitivity for detection of coronary 
artery disease than d exercise testing (89% vs. 55%). 
agreement with the ults of previous reports utilizing ec 
cardiography with dob~ta~~~e (1-6) or other forms of stress 
(31,32). 
In the present study, we utilized ~70% stenosis ts indica- 
tive of coronary artery disease. However, there is no universal 
agreement on the severity of stenosis that best reflects 
ologic significance. In previous tudies related to stress 
nt lumen narrowing used to dete 
disease has varied between ~50% 
(1,3-5,9,17,19,343!,33) and~70% (2,6,18,20,21,25,32). When 
we analyzed our results considering vessel stenoses ~50%, no 
substantial differences were found in the ability of transesoph- 
ageal dobutamine stress echocardiography to accurately detect 
coronary artery disease. Thus, when we used ~50% stenosis as 
a marker, the sensitivity and specificity of this technique were 
87% and lOO%, respectively, the positive predictive value Was 
100% and the overall accuracy was 89%. Among the patients 
with coronary artery disease, the sensitivity and specificity for 
diagnosis of multivessel involvement were 75% and 87% 
respectively. 
Previous tudies (17-21) have reported on the usefulness Of
transesophageal chocardiograpl;y combined with transesoph- 
atrial pacing and with dipyridamole administration. 
ver, dobutamine may be preferable to those interven- 
tions because it produces greater increases in demand than 
those induced by atrial pacing, and because, in contrast to the 
induction of ischemia by dipyridamole (341, the increases in 
work load with graded doses of dobutamine mimic those 
observed uring exercise testing, the most physiologic form of 
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stress. we utilized a relatively slow protocol of work load 
increments by increasing the dose of dobutmine by only 
5 pflg per min in each stage. However, we believe that the 
protocol may be modified to one with brisker increases in work 
load (and consequent reduction i total esophageal intubatiou 
time) in patients with normal left ventricular function. In 
PtjentS with depressed systolic function, a SiOW prOtOCOi jS 
probably preferable for two reasons: 1)to increase the chance 
of identifying enhanced systolic wall thickening indicative of
myocardial viability before myocardial schemia is produced 
with higher doses; and 2) to reduce the incidence of side etrects 
that may develop inthese patients if protocols with more rapid 
increa,ses in work load are used. 
In contrast to previous studies of transeso~~~~eai str ss
~cboc~rdi~~~~hy (1%19), we uti~~~d either a ~~~l~n~ or an 
omnipiene probe. The use of those probes (pitrticulariy the 
omniplanc probe) eilows cxaminntion f the left ventrisic from 
multiple planes (28) and reduces discomfort tothe patient. For 
these reasons we believe that, if available, the ll~nni~)iaue probe 
should he the ~r~)~ of choice for patients under~oiu~ trans- 
esophageal stress ec~~~rdi~~~~a~hy. 
Our findiags may have important impiica- 
the clinical assessment a d investigation f coronary 
artery disease. First, our study indicates that dobutamine- 
induced stress i  feasible during transesophageai echocardio- 
graphic examination and its use should therefore b  consi&;;d in 
patients who are candidates forstress echocardiography but ave 
a suboptimal transthoncic ultrasound window. Second, because 
of the high quality images rendered by the transe I 
examination, the technique is ideally suited for cliniwi 
tions of ischemic heart disease utilizing cardiac u~t~~und, such 
as contrast ech~ardiography, t ree.dimensionai rcconst 
of the left ventricle and myocardial tissue ch~~~~~cter~z~~ti~l~ 
the ability to obtGn high q~~~i~ images ofthe left ventricle 
be important for quantitative a,&sessment of myocardial wail 
thickening, particularly in patients with depressed l ft ventricular 
function i whom identi%zlion f viable myocardium, and con- 
sequently he decision toundergo re~uia~tion, may depend 
on analysis of the response to dobutamine (10-14). 
Our patients were not selected on the basis of a suboptimal 
ultrasound transthoracic examination, a d no comparison was 
made belween transesophageai and transthoracic echocardiog 
raphy during dobutamine stress. Therefore, we cannot ascer- 
tain from our study the proportion ofpatients with coronary 
artery disease who need a transesophageal ex mination for
reliable assessment of the echocardiographic response to 
stress. Ifl fi\ot, the proportion ofpatients unable to undergo a 
dobutamine stress test because of unacceptable echocardio- 
graphic mages with the transthoracic approach is also difficult 
10 estimate from a review of published medical reports and 
ranges from 0% (1,3) to -20% (2). This range may reflect 
differences in the operators’ skills, the interpreters’ experience 
and the use of videotape or digitizing systems for image 
analysis. However, probably the most important consideration 
is the fact that the definition of a suboptimal echocardio- 
graphic study is necessarily subjective and therefore variable 
among different laboratories. For exampie, ii visualization f 
~10 of 16 myocardial segments is considered imal, 24% 
of our patients had a sub 
defined. Lower thresh0 
proportion of suboptimal studies. Because factors that inter- 
fere with an optimal echocardiographic exam~~~t~o~, such as
advanced age, obesity, history of smoking, chronic obstructive 
pulmonary disease and previous open heart 
uncommon among patients w
reasonable to assume that - 1 
condition may have a suboptimal transth 
window and may. therefore. besncfit 
examination. However, the :actual bene 
from ~~~s~~ctivc studies in ~v~l~ch dobut 
f~~ru~e~ with both tr~ust~or~cic and transc: 
tha: transtbor~cic c~au~ination, requires ~~~ticut se 
i a small risk for serious c~~~~~ic~~ti~~s (35). In the 
1 study, we found an extremc~y low iucidc~lc~ of com- 
plications or side effects. Indeed, no major complications 
developed, and the side c@ects ntcd to dobutamine infusion 
were self-limited and did not a t thr diagnostic a curacy of
the test, in agreemcut wit 
safety of dobutamiue stress ecboca~dio~~a~~~y in a large
ulation of ~atieuts with ku~wn orsuspected coronary a
disease (36). The studies were well tolerated by the vast 
majority of patients and dis ntinuation ofthe study because 
of il~t~~iera~~c~ to the probe cted the diagi~~stic ac uracy of 
the test in only 1 of the 76 patients. 
Even though atropine was not used inany patietat, only one 
patient did not achieve 85% of the age-predicted maximal 
heart rate: this patient w;\s the one in whom intolerance to the 
probe developed prematurely d the test. Thus, although 
previous studies (33) have shown 
increase the sensitivity of dobutamine 
we do not believe that not using atropine ue~ativeiy 
the accuracy of our studies. However, we emphasize that ail of 
qur study patients underwent their examination after with- 
drawal of antianginal medications and received a relatively 
high peak dose of dobutamine (40 PgIkg per min). It is our 
experience, therefore, that the need for atropine to achieve a 
target heart rate is rare under these circumstances. 
Finally, we found an excellent rate of agreement between 
independer.: observers in the interpretation of the echocardio- 
graphic examinations. The reiativeiy small interobserver ari- 
ability was largely related to the presence ofrest wall motion 
abnormalities with severe left ventricular systolic dysfunction. 
Conelusiolas. The findings of the present study indicate 
that ransesophageal dobutamine stress echocardiography is a 
safe, feasible and accurate method for assessing coronary 
artery disease. its use, therefore, should be considered in
patients who are candidates for stress echocardiography but 
have a suboptimal ultrasound window, and in those in whom 
accurate measurements of ystolic wall thickening are critical 
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